Common use of General Development Activities Clause in Contracts

General Development Activities. In consideration for the information and results arising from the General Development Activities, which information and results may be useful for obtaining Regulatory Approval in the Field in the Territory and would be delivered to Ono pursuant to Section 5.1, the Parties shall share Development Costs incurred by Onyx from [*] through [*], with respect to any General Development Activities, with Onyx bearing [*] percent ([*]%) of such costs and Ono bearing (i.e., reimbursing Onyx for) the remaining [*] percent ([*]%) of such costs (including, for clarity, [*] and [*]); provided that, Ono’s obligation to share in such costs shall be capped at [*] per [*], and at a total of [*] for such [*] ([*]) [*] period. From and after [*], Onyx shall be responsible for [*] of all Development Costs incurred by Onyx with respect to any General Development Activities. In furtherance of the foregoing, within [*] following the end of each [*] after the [*], Onyx shall prepare and deliver to Ono a [*] report detailing the Development Costs incurred with respect to Development Activities during such period with such costs broken-down in reasonable detail, as well as an invoice for the amount of such Development Costs which Ono is responsible for pursuant to this Section 4.4.1; provided that, the [*] such invoice shall also include [*] incurred by Onyx with respect to Development Activities [*] by Onyx [*]. Ono shall pay the amount of such Development Costs within [*] ([*]) [*] of its receipt of each such invoice and such [*] report; provided that, Onyx shall submit any additional information reasonably requested by Ono related to such costs included in its report within [*] ([*]) [*] of its receipt of [*] = Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended. such request. As of the 2013 Effective Date, the General Development Activities include, among other things, the studies set forth on Schedule 4.4.1.

Appears in 1 contract

Sources: License Agreement (Onyx Pharmaceuticals Inc)

General Development Activities. In consideration for the information and results arising from the General Development Activities, which information and results may be useful for obtaining Regulatory Approval in the Field in the Territory and would be delivered to Ono pursuant to Section 5.1, the Parties shall share Development Costs incurred by Onyx from [**] through [**], with respect to any General Development Activities, with Onyx bearing [**] percent ([**]%) of such costs and Ono bearing (i.e., reimbursing Onyx for) the remaining [**] percent ([**]%) of such costs (including, for clarity, [**] and [**]); provided that, Ono’s obligation to share in such costs shall be capped at [**] Dollars ($[**]) per [**], and at a total of [**] Dollars ($[**]) for such [**] ([**]) [**] period. From and after [**], Onyx shall be responsible for [*] one hundred percent (100%) of all Development Costs incurred by Onyx with respect to any General Development Activities. In furtherance of the foregoing, within [**] following the end of each [**] after the [**], Onyx shall prepare and deliver to Ono a [**] report detailing the Development Costs incurred with respect to Development Activities during such period with such costs broken-down in reasonable detail, as well as an invoice for the amount of such Development Costs which Ono is responsible for pursuant to this Section 4.4.1; provided that, the [**] such invoice shall also include [**] incurred by Onyx with respect to Development Activities [**] by Onyx [**]. Ono shall pay the amount of such Development Costs within [**] ([**]) [**] of its receipt of each such invoice and such [**] report; provided that, Onyx shall submit any additional information reasonably requested by Ono related to such costs included in its report within [**] ([**]) [**] of its receipt of [*] = Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended. such request. As of the 2013 Effective Date, the General Development Activities include, among other things, the studies set forth on Schedule 4.4.1.

Appears in 1 contract

Sources: License, Development and Commercialization Agreement (Onyx Pharmaceuticals Inc)